Steris | STE - Sales Revenues


Steris reported $1.5B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
3M USD 6.5B 500M Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
CONMED USD 343.5M 26.5M Jun/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
Dexcom USD 1.31B 120M Jun/2026
Ecolab USD 4.41B 340M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Fortive USD 1.1B 30M Jun/2026
Getinge SEK 8.38B 1000K Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Haemonetics USD 339M 7M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Olympus JPY 240.4B 54.88B Jun/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Steris USD 1.5B 90M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026